Only a few months after Medtronic completed its acquisition of cardiac device maker Affera, the nearly billion-dollar buyout is already paying off. A dual-use catheter originally developed by Affera ...

Over the last weekend, Chicago played host to the 2026 edition of the Heart Rhythm Society's annual conference (HRS 2026).

Please provide your email address to receive an email when new articles are posted on . The FDA approved a mapping and dual-energy catheter ablation system for treatment of persistent AF. The system ...

The cardiac ablation market growth is driven by the rising prevalence of cardiac arrhythmias, increasing awareness of minimally invasive treatment options, and technological advancements in ablation ...

Enrollment completed ahead of schedule in the global IDE for Abbott (ABT)'s Volt™ PFA System Global FOCALFLEX trial now underway for Abbott's TactiFlex™ Duo Ablation Catheter, Sensor Enabled™ Advisor™ ...

After eight years of failed treatment for persistent atrial fibrillation (AF), a New Jersey patient became the first patient in the United States to undergo cardiac ablation -- a procedure in which an ...

New publications in Heart Rhythm and Europace demonstrate how single-beat mapping provides instant clinical clarity, ...

(RTTNews) - Boston Scientific Corp. (BSX) said it has received U.S. Food and Drug Administration approval for the navigation-enabled FARAWAVE NAV Ablation Catheter for the treatment of paroxysmal ...

Abbott today announced it has received clearance from the U.S. Food and Drug Administration for the EnSite™ X EP System with EnSite Omnipolar Technology (OT), a new cardiac mapping platform available ...

Biosense Webster, Inc., part of Johnson & Johnson MedTech, today announced the European launch of the HELIOSTAR ™ Balloon Ablation Catheter – the first radiofrequency balloon ablation catheter – The ...

Dublin, Jan. 23, 2026 (GLOBE NEWSWIRE) -- The "Cardiac Mapping Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031" has been added to ResearchAndMarkets.com's ...

PHILADELPHIA - After eight years of failed treatment for persistent atrial fibrillation (AF), Janet Szilagyi, 78 of Clayton, New Jersey, became the first patient in the United States to undergo ...